share_log
Breakings ·  Jun 20 20:00
J&J: Tremfya(®) Phase 3 Crohn's Disease Study Achieves All Primary and Secondary Endpoints
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment